| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/12/1996 | CA2212125A1 Process for producing a protein |
| 09/11/1996 | EP0730869A1 Biodegradable medicinal polymer assembly with supermolecular structure |
| 09/11/1996 | EP0730661A1 Compounds with pth activity and recombinant dna vectors encoding same |
| 09/11/1996 | EP0730568A1 Amphiphilic derivatives of piperazine |
| 09/11/1996 | EP0730494A1 Particles for binding monovalent cations and their use |
| 09/11/1996 | EP0730493A1 Use of a polymer material based on modified hydrocolloids as encapsulating material |
| 09/11/1996 | EP0730474A1 Estramustine formulations with improved pharmaceutical properties |
| 09/11/1996 | EP0730473A1 Hirudin conjugates from hirudin and lipophilic compounds |
| 09/11/1996 | EP0730472A1 Immobilized labelling method |
| 09/11/1996 | EP0730470A1 Improved interferon polymer conjugates |
| 09/11/1996 | EP0730464A1 Composition comprising sulcralfate and an antimicrobial agent/ion-exchange resin complex |
| 09/11/1996 | EP0730457A1 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injuri |
| 09/11/1996 | EP0730450A1 Plaster for treating nail mycoses |
| 09/11/1996 | EP0730447A1 Fatty acid delivery system |
| 09/11/1996 | EP0730444A1 Sustained release formulations for 24 hour release of metoprolol |
| 09/11/1996 | EP0730405A1 Amphiphilic derivatives of guanidine |
| 09/11/1996 | EP0730404A1 Amphiphilic imidazolinium derivatives |
| 09/11/1996 | EP0696192A4 Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof |
| 09/11/1996 | EP0632719B1 Method of treatment of infected tissues |
| 09/11/1996 | EP0621777B1 Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies |
| 09/11/1996 | EP0592564B1 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology |
| 09/11/1996 | EP0581862B1 Dosage forms comprising polymers comprising different molecular weights |
| 09/11/1996 | EP0534944B1 Antibodies specific for elam-1 and the use thereof |
| 09/11/1996 | CN1130944A Diagnostic prognostic and therapeutic method for solid non-lymphoid tumors and their metastases |
| 09/11/1996 | CN1130876A Compounds for prevention and treatment of helminth infections |
| 09/11/1996 | CN1130866A Anti-angiogenic compositions and method of use |
| 09/11/1996 | CN1130864A Personal cleansing compositions |
| 09/11/1996 | CN1130863A Composition containing phosphate derivatives |
| 09/11/1996 | CN1130506A Pharmaceutical formulations of cefaclor |
| 09/10/1996 | US5554748 Adducts of macrocyclic chelants |
| 09/10/1996 | US5554730 Vaccines |
| 09/10/1996 | US5554654 Method for enhancing the therapeutic effect of an anti-acne agent |
| 09/10/1996 | US5554652 Topically applying mixture to reduce or prevent skin disorders |
| 09/10/1996 | US5554651 Method of treating wrinkles using citramalic acid |
| 09/10/1996 | US5554618 Intravenously administrable aqueous solution |
| 09/10/1996 | US5554598 Method of treating crural or decubitus ulcer with zinc hyaluroric acid complex |
| 09/10/1996 | US5554597 Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging |
| 09/10/1996 | US5554508 Process for the enzymatic synthesis of alkyl esters of peptides and peptides, and microparticles therefrom |
| 09/10/1996 | US5554388 Systemic drug delivery compositions comprising a polycationi substance |
| 09/10/1996 | US5554387 Sustained release heterodisperse hydrogel systems for insoluble drugs |
| 09/10/1996 | US5554386 Complexing; internalization into cells by receptor mediated endocytosis |
| 09/10/1996 | US5554384 High dose formulations of mycophenolate mofetil and mycophenolic acid |
| 09/10/1996 | US5554378 Pharmaceutical composition and its mucosal use |
| 09/10/1996 | US5554367 Compositions for treatment of glaucoma |
| 09/10/1996 | US5554365 Use of cyanoacrylate adhesive compositions to inhibit acute radiation-induced skin damage |
| 09/10/1996 | CA2036507C 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions |
| 09/06/1996 | WO1996026950A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives |
| 09/06/1996 | WO1996026890A2 Method of producing hydrophilic or partially hydrophilic inorganic aerogels |
| 09/06/1996 | WO1996026738A1 Pharmaceutical compositions for controlled release of soluble receptors |
| 09/06/1996 | WO1996026737A1 Morphogen-induced dentine regeneration |
| 09/06/1996 | WO1996026726A1 Pharmaceutical composition for piperidinoalkanol compounds |
| 09/06/1996 | WO1996026718A2 Controlled release tablet |
| 09/06/1996 | WO1996026717A1 Sustained release formulation containing three different types of polymers |
| 09/06/1996 | WO1996026716A1 Elcatonin controlled release microsphere formulation for treatment of osteoporosis |
| 09/06/1996 | WO1996026710A1 Cosmetic and/or pharmaceutical preparations |
| 09/06/1996 | WO1996021470A3 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy |
| 09/06/1996 | WO1996021036A3 Nucleic acid condensing agents with reduced immunogenicity |
| 09/06/1996 | WO1996020688A3 Triggered pore-forming agents |
| 09/06/1996 | WO1996020208A3 New cholesterol derivative for liposomal gene transfer |
| 09/06/1996 | WO1996018372A3 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| 09/06/1996 | CA2214341A1 Morphogen-induced dentine regeneration |
| 09/06/1996 | CA2213455A1 Controlled release tablet |
| 09/06/1996 | CA2189358A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives |
| 09/05/1996 | DE19507203A1 Kosmetische und/oder pharmazeutische Zubereitungen Cosmetic and / or pharmaceutical preparations |
| 09/05/1996 | DE19504831A1 Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose Fixed drug preparations containing hydroxypropyl cellulose |
| 09/04/1996 | EP0729781A1 Surfactant, and emulsion cosmetic and liposome each containing the same |
| 09/04/1996 | EP0729756A1 Granular preparation |
| 09/04/1996 | EP0729751A1 Controlled release formulation containing tramadol |
| 09/04/1996 | EP0729747A1 Use of amphiphilic compounds as thickening agent of non aqueous media and composition obtained |
| 09/04/1996 | EP0729745A1 Vitamin C delivery system |
| 09/04/1996 | EP0729363A1 Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors |
| 09/04/1996 | EP0729357A1 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 09/04/1996 | EP0729353A1 Preparation of biodegradable microparticles containing a biologically active agent |
| 09/04/1996 | EP0729351A1 Vesicles with controlled release of actives |
| 09/04/1996 | EP0506884B1 Method of delivering molecules into eukaryotic cells |
| 09/04/1996 | CN1130352A Controlled-releasing opioid formulations for treating pain |
| 09/04/1996 | CN1130064A Solid medicinal composition containing ecipient capable of combining water |
| 09/04/1996 | CN1130060A Ketopheny/propionate plastid |
| 09/03/1996 | US5552428 Antiarrhythmia agents for cardiovascular disorders using melatonin derivatives |
| 09/03/1996 | US5552391 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 09/03/1996 | US5552378 Solid consumer product compositions containing small particle cyclodextrin complexes |
| 09/03/1996 | US5552311 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 09/03/1996 | US5552184 Coating agents, their use as clear coats and processes for the production of multicoat lacquer finishes |
| 09/03/1996 | US5552153 Pharmaceutical composition for transdermal delivery |
| 09/03/1996 | US5552086 Gold and silver on polystyrene, useful for raman spectroscopy and flow cytometry, interlayer of aminodextran |
| 09/03/1996 | CA2033113C Estrogen-containing gel preparation |
| 08/29/1996 | WO1996026274A1 Antagonists of interleukin-15 |
| 08/29/1996 | WO1996026179A1 Novel cationic lipids and the use thereof |
| 08/29/1996 | WO1996025956A2 Individual medicament dosing conjugate |
| 08/29/1996 | WO1996025952A1 Pharmaceuticals and assays using enzyme subunits |
| 08/29/1996 | WO1996025951A1 Gel form of a vaccine |
| 08/29/1996 | WO1996025950A1 Use of inorganic aerogels in pharmacy |
| 08/29/1996 | WO1996025947A2 Induction of e-selectin for targetting therapeutic agents |
| 08/29/1996 | WO1996025942A1 Cochleate phospholipids in drug delivery |
| 08/29/1996 | WO1996025939A1 Use of piperine as a bioavailability enhancer |
| 08/29/1996 | WO1996025921A1 Polyalkylene block copolymers as surface modifiers for nanoparticles |
| 08/29/1996 | WO1996025920A1 Cosmetic melanins |
| 08/29/1996 | WO1996025919A1 Aerosols containing beclomethazone nanoparticle dispersions |
| 08/29/1996 | WO1996025912A1 Method for topical treatment of scar tissue and related tissue reaction to trauma |
| 08/29/1996 | WO1996025850A1 Use of aerogels in agriculture |